⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29353832 | 1.00 | — | — | |
| SCHEMBL5733314 | 1.00 | PNMT (0.60) | — | |
| SCHEMBL11028540 | 0.98 | PNMT (0.58) | — | |
| SCHEMBL1001013 | 0.98 | PNMT (0.58) | — | |
| SCHEMBL10876787 | 0.91 | PNMT (0.52) | — | |
| SCHEMBL27599728 | 0.89 | PNMT (0.50) | — | |
| SCHEMBL10987297 | 0.87 | TAAR1 (0.55) | — | |
| SCHEMBL20815578 | 0.84 | CYP3A4 (0.46) | — | |
| SCHEMBL25840770 | 0.83 | TSHR (0.65) | — | |
| SCHEMBL10879362 | 0.82 | SLC6A4 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3003 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375643-B | Deaconitine derivative and preparation method and application thereof | 中国人民解放军海军军医大学 | 2025-04-01 | — | — | CN | claimed |
| CN-119101052-A | Matrine-triazole derivative and synthesis method thereof | 吉林医药学院 | 2024-12-10 | — | — | CN | claimed |
| CN-118221691-B | Methylenedioxybenzo [ b ] [1,4] diazepine [5,6-e ] triazinone derivative and pharmaceutically acceptable salt, preparation method and application thereof | 常熟理工学院 | 2024-10-15 | — | — | CN | claimed |
| CN-117986413-A | Catalyst component with high hydrogen regulation sensitivity, preparation method thereof, catalyst and application | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-114773330-B | Butylphthalide-oxa/thiadiazole compound and preparation method and application thereof | 贵州医科大学 | 2024-03-15 | — | — | CN | claimed |
| CN-116715624-A | Synthesis method of N-alkylated pyrithione compound | 信阳师范学院 | 2023-09-08 | — | — | CN | claimed |
| CN-116375643-A | Deaconitine derivative and preparation method and application thereof | 中国人民解放军海军军医大学 | 2023-07-04 | — | — | CN | claimed |
| CN-112047928-B | Isonicotinamide AChE-GSK3 double inhibitor and preparation method and application thereof | 中国药科大学 | 2022-09-23 | — | — | CN | claimed |
| CN-114773330-A | Butylphthalide-oxa/thiadiazole compound and preparation method and application thereof | 贵州医科大学 | 2022-07-22 | — | — | CN | claimed |
| CN-112047928-A | Isonicotinamide AChE-GSK3 double inhibitor and preparation method and application thereof | 中国药科大学 | 2020-12-08 | — | — | CN | claimed |
| CN-110117252-A | A kind of preparation process of 2-aminopyridine -6- methyl formate | 南京博源医药科技有限公司 | 2019-08-13 | — | — | CN | claimed |
| US-20260146046-A1 | BICYCLIC FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2026-05-28 | — | — | US | disclosed |
| WO-2026107371-A2 | INDOLYL-PYRIDINONES AND RELATED COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-122055361-A | Fascin inhibitors | 北京双鹤润创科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4741018-A2 | SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2026-05-13 | — | — | EP | disclosed |
| US-4004016-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1977-01-18 | — | — | US | disclosed |
| US-3970671-A | XANTHENE, PRESSURE SENSITIVE | KANZAKI PAPER MANUFACTURING CO., LTD. (JA) | 1976-07-20 | — | — | US | disclosed |
| US-3953425-A | Azepine indanyl and tetralin butyrophenones | THE UPJOHN COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3947471-A | CHROMOGENIC | SUMITOMO CHEMICAL COMPANY, LTD. (JA) | 1976-03-30 | — | — | US | disclosed |
| US-3932425-A | CNS DEPRESSANT, BLOOD PRESSURE LOWERING | THE UPJOHN COMPANY (US) | 1976-01-13 | — | — | US | disclosed |